Atoncy Solution
Product Images NDC 30698-456

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Atoncy (NDC 30698-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Validus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Atomoxetine HCl Os 4mg mL Bottle Label)

Label for ATONCY (atomoxetine hydrochloride) oral solution, 4 mg/mL, 100 mL bottle. The label indicates the product is for prescription use only, dispensed by Validus Pharmaceuticals LLC, and includes storage instructions along with a discard date scale. The label emphasizes keeping the solution tightly closed and out of reach of children.*

FDA Label Image

"image Description" (Atomoxetine HCl Os 4mg mL Carton Label)

Packaging label for ATONCY (atomoxetine hydrochloride) Oral Solution 4 mg/mL by Validus Pharmaceuticals LLC. The 100 mL oral solution carton includes instructions for pharmacists to dispense the accompanying medication guide to patients. It displays storage instructions, dosage information, and contents including a dosing syringe and press-in bottle adapter. The product is indicated for oral use only and is marked Rx only.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 1)

An instructional illustration showing components of ATONCY (atomoxetine hydrochloride) oral solution 4 mg/mL packaging. The image labels the bottle, cap, and bottle adapter on the left, and details parts of a 10 mL oral dosing syringe on the right, including the tip, barrel with volume markings, and plunger.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 10)

An instructional illustration showing a hand using a syringe to measure a dose from a bottle of Atoncy (atomoxetine hydrochloride) oral solution 4 mg/mL. The image highlights the measurement of the dose on the syringe and the Atoncy solution bottle labeled with the product name, strength, and labeler Validus Pharmaceuticals LLC.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 11)

A black and white line drawing illustration of a person taking oral medication using a syringe to administer liquid drug into the mouth, demonstrating oral administration of a solution.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 2)

An illustration showing a human hand washing under running water from a faucet, emphasizing proper hand hygiene technique.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 3)

Instructional illustration showing how to open ATONCY (Atomoxetine hydrochloride) oral solution bottle. The image depicts pressing down and turning the child-resistant cap, removing it along with the bottle adapter, revealing the bottle. The bottle and its components are labeled for clarity.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 4)

An instructional diagram showing a hand pressing down on the cap of a small bottle while simultaneously twisting it to open, illustrating the use of a child-resistant safety cap on the medication bottle.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 5)

An instructional diagram showing a hand holding a bottle of ATONCY oral solution with a syringe dispensing a dose from the bottle. The image highlights the steps to draw the correct dose from the bottle using the syringe, with labeled pointers indicating the dose and the bottle.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 6)

An instructional illustration showing a hand holding a syringe above an open bottle with an attached adapter. The image demonstrates the step of inserting the syringe into the adapter on the bottle, indicated by a downward arrow, likely for drawing the liquid medication.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 7)

An instructional illustration showing a hand holding a bottle of liquid medication inverted, with the bottle's nozzle inserted into a dosing syringe marked from 2 to 10 mL. Another hand is shown sliding the plunger of the syringe up and down, indicating how to draw the medication into the syringe.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 8)

An instructional illustration showing the proper method to draw liquid medication from a bottle into an oral syringe. A hand holds an upright bottle dispensing liquid into the syringe, while another hand steadies the syringe. An inset highlights the liquid inside the syringe, emphasizing the measurement markings.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Figure 9)

An instructional illustration showing how to measure a liquid dose using a 10 mL graduated cylinder. A bottle is inverted above the cylinder, dispensing liquid, with a close-up inset highlighting the volume measurement (dose) on the cylinder's scale.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Graph 1)

A pair of line graphs displaying changes in mean weight percentile and mean height percentile over 36 months of treatment. The left graph shows mean weight percentile with a sample size of 203, illustrating a decline initially followed by a gradual increase. The right graph shows mean height percentile with a sample size of 155, indicating slight fluctuations around a stable level across the time period.*

FDA Label Image

"image Description" (Atomoxetine HCl Os Structure)

Chemical structure diagram of Atomoxetine hydrochloride, showing its molecular connectivity including aromatic rings, methyl groups, and an amine hydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.